Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Bone Marrow Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1705497PMID 16400341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

  2005cited by this paper
• Chronic graft versus host disease

  2004cited by this paper
• Graft‐versus‐host disease (GVHD)‐specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic haematopoietic cell transplantation

  2003cited by this paper
• Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.

  2003cited by this paper
• Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

  2002cited by this paper
• Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.

  2001cited by this paper
• Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.

  2001cited by this paper
• Development of a prognostic model for grading chronic graft-versus-host disease.

  2001cited by this paper
• Genetic Clues Revise View of Japanese Roots

  1999cited by this paper
• Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.

  1998cited by this paper
• Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

  1998cited by this paper
• The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation

  1998cited by this paper
• Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese.

  1995cited by this paper
• Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.

  1994cited by this paper
• Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

  1991cited by this paper
• Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation.

  1990cited by this paper
• Predictors of death from chronic graft-versus-host disease after bone marrow transplantation.

  1989cited by this paper
• Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group

  1989cited by this paper
• Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.

  1988cited by this paper
• The histopathology of graft-versus-host disease.

  1986cited by this paper
• Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants.

  1983cited by this paper
• Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

  1981cited by this paper
• Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

  1980cited by this paper

• Graft-versus-host disease after an outpatient peripheral blood hematopoietic cell transplant using reduced-intensity conditioning: a single-center LATAM experience

  2024cites this paper
• Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation

  2022cites this paper
• Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan

  2022cites this paper
• Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors

  2021cites this paper
• A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort.

  2020cites this paper
• Evolving concepts in prognostic scoring of chronic GvHD

  2017cites this paper
• Classification systems for chronic graft-versus-host disease.

  2017cites this paper
• Cornea Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease

  2017cites this paper
• Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease.

  2017cites this paper
• Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.

  2016influential citation
• Series CHRONIC GRAFT-VERSUS-HOST DISEASE Classi fi cation systems for chronic graft-versus-host disease

  2016cites this paper
• Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation

  2015cites this paper
• Risk factors and organ involvement of chronic GVHD in Japan

  2014cites this paper
• Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.

  2013cites this paper
• transplantation: retrospective survey involving 1072 patients in Japan Chronic graft-versus-host disease following umbilical cord blood

  2013cites this paper
• Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.

  2012cites this paper
• Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria

  2011cites this paper
• Immune Reactions following Cord Blood Transplantations in Adults

  2011cites this paper
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission

  2010cites this paper
• Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease

  2009cites this paper
• Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT

  2009cites this paper
• Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.

  2009influential citation
• Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults

  2008cites this paper
• Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1072 patients in Japan.

  2008cites this paper
• Infectious complications in chronic graft‐versus‐host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced‐ and conventional‐intensity conditioning regimens

  2008cites this paper
• Chapter 2 Stem Cell Transplantation for Hematologic Malignancies

  2008cites this paper
• Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

  2007cites this paper
• Greffes allogéniques à partir de donneurs non apparentés

  2007cites this paper
• Chronic graft‐versus‐host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program

  2007cites this paper